Many high street CBD products must be removed from sale, research shows

12th April 2022 - Press releases , Resources |

FOR IMMEDIATE RELEASE Many high street CBD products must be removed from sale, research shows The majority of CBD oral products now on the UK market will have to be removed from sale, significantly affecting many retailers and consumers, new analysis from CBD-Intel suggests. CBD-Intel compared the recent Food Standards Agency (FSA) list of oral CBD products which are allowed » Continue Reading.

How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?

22nd April 2021 - Blogs |

It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.

Is delta-8 THC really the next big thing?

14th April 2021 - Blogs |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blogs |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.

Is the entrance of British American Tobacco (BAT) into the CBD sector a positive or negative for the industry?

22nd January 2021 - Blogs |

The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango and berry – and two strengths – 50 mg at £9.99 and 100 mg at £14.99) would be priced at the higher end of » Continue Reading.

Do CBD firms expect much of a January uptick in sales?

18th December 2020 - Blogs |

It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black Friday at the end of November into the gift-giving Christmas and other holidays period through December. Overall, the market is still too » Continue Reading.